Annette Feuchtinger Selected Research

gadofluorine

1/2020

Mass Spectrometry Imaging of atherosclerosis-affine Gadofluorine following Magnetic Resonance Imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annette Feuchtinger Research Topics

Disease

35	Neoplasms (Cancer) 10/2022 - 12/2011
8	Adenocarcinoma 01/2022 - 08/2012
8	Obesity 01/2021 - 10/2018
6	Body Weight (Weight, Body) 01/2021 - 11/2015
6	Type 2 Diabetes Mellitus (MODY) 11/2018 - 01/2016
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2011
5	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
4	Insulin Resistance 01/2021 - 01/2016
4	Fibrosis (Cirrhosis) 01/2021 - 11/2013
3	Fatty Liver 01/2021 - 01/2017
3	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2017
3	Hyperglycemia 10/2020 - 01/2016
3	Adenoma (Adenomas) 01/2020 - 04/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
2	Residual Neoplasm 01/2022 - 12/2012
2	Lung Neoplasms (Lung Cancer) 12/2021 - 12/2017
2	Atherosclerosis 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 05/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 08/2013
2	Hypertension (High Blood Pressure) 01/2020 - 04/2017
2	Hyperaldosteronism (Conn Syndrome) 01/2020 - 04/2017
2	Adrenocortical Carcinoma 10/2019 - 01/2019
2	Cicatrix (Scar) 04/2018 - 03/2014
2	Myocardial Infarction 04/2018 - 03/2014
2	Infarction (Infarctions) 04/2018 - 03/2014
2	Disease Progression 12/2016 - 10/2010
2	Breast Neoplasms (Breast Cancer) 07/2016 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 11/2013
2	Colorectal Neoplasms (Colorectal Cancer) 03/2015 - 05/2013
2	Sarcoma (Soft Tissue Sarcoma) 11/2014 - 01/2013
2	Lymphoma (Lymphomas) 01/2013 - 10/2012
2	Uveitis 05/2011 - 10/2010
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Endotoxemia 01/2022
1	Anthracosis 12/2021
1	Carcinogenesis 12/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Lipodystrophy 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hypersensitivity (Allergy) 01/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2010
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2012
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2015
5	Pharmaceutical PreparationsIBA 01/2017 - 11/2014
3	LipidsIBA 12/2021 - 01/2017
3	Peptides (Polypeptides)IBA 01/2021 - 01/2019
3	AldosteroneIBA 01/2020 - 04/2017
3	Sorafenib (BAY 43-9006)FDA Link 10/2015 - 01/2013
2	CytokinesIBA 01/2022 - 12/2017
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2021
2	Polysaccharides (Glycans)IBA 12/2021 - 09/2017
2	Biological ProductsIBA 12/2021 - 12/2016
2	Phosphotransferases (Kinase)IBA 06/2021 - 12/2017
2	Contrast MediaIBA 01/2021 - 03/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2021
2	GlucocorticoidsIBA 01/2021 - 04/2017
2	IntegrinsIBA 01/2021 - 01/2017
2	gadofluorine PIBA 01/2020 - 04/2018
2	SteroidsIBA 10/2019 - 04/2017
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2019 - 10/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2018 - 10/2018
2	Gadolinium DTPA (Magnevist)FDA Link 04/2018 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 09/2017 - 05/2013
2	Insulin (Novolin)FDA Link 06/2017 - 01/2016
2	BezafibrateIBA 01/2017 - 01/2016
2	Cathepsin BIBA 07/2016 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2016 - 01/2016
2	Urokinase Plasminogen Activator ReceptorsIBA 07/2016 - 01/2016
2	Plasminogen Activator Inhibitor 1IBA 07/2016 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 11/2014
2	CollagenIBA 01/2015 - 11/2013
2	Retinaldehyde (Retinal)IBA 07/2014 - 05/2011
1	Immune Checkpoint InhibitorsIBA 10/2022
1	NucleotidesIBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 12/2021
1	CarbonIBA 12/2021
1	SootIBA 12/2021
1	NitrosaminesIBA 12/2021
1	AminesIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	xanthurenic acidIBA 06/2021
1	P-2 (P 2)IBA 06/2021
1	Sialic AcidsIBA 06/2021
1	Inositol (Myoinositol)IBA 06/2021
1	KynurenineIBA 06/2021
1	Insulin ReceptorIBA 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021

Therapy/Procedure

26	Therapeutics 10/2022 - 10/2012
7	Lasers (Laser) 03/2022 - 12/2011
4	Cyclotrons 03/2022 - 01/2018
3	Aftercare (After-Treatment) 01/2022 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
2	Neoadjuvant Therapy 01/2022 - 01/2022